Arcus Biosciences (RCUS) Operating Income: 2017-2025
Historic Operating Income for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to -$142.0 million.
- Arcus Biosciences' Operating Income fell 35.24% to -$142.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$375.0 million, marking a year-over-year decrease of 17.92%. This contributed to the annual value of -$330.0 million for FY2024, which is 2.94% up from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Operating Income is -$142.0 million, which was down 1,675.00% from -$8.0 million recorded in Q2 2025.
- Arcus Biosciences' Operating Income's 5-year high stood at $281.0 million during Q4 2021, with a 5-year trough of -$142.0 million in Q3 2025.
- Over the past 3 years, Arcus Biosciences' median Operating Income value was -$91.0 million (recorded in 2023), while the average stood at -$85.6 million.
- Within the past 5 years, the most significant YoY rise in Arcus Biosciences' Operating Income was 642.75% (2021), while the steepest drop was 5,134.54% (2021).
- Arcus Biosciences' Operating Income (Quarterly) stood at $281.0 million in 2021, then crashed by 126.33% to -$74.0 million in 2022, then dropped by 22.97% to -$91.0 million in 2023, then dropped by 13.19% to -$103.0 million in 2024, then tumbled by 35.24% to -$142.0 million in 2025.
- Its Operating Income was -$142.0 million in Q3 2025, compared to -$8.0 million in Q2 2025 and -$122.0 million in Q1 2025.